Back to today’s briefing

Story perspectives

Recursion's AI Revolutionizes Clinical Trials for Rare Diseases

5/12/2025

44 6

Summary

Story summary

Recursion is transforming clinical trials with its innovative AI-powered "ClinTech" strategy, as highlighted by SVP Sid Jain. By embedding AI throughout trial design and execution, the company aims to enhance patient-centric methods and streamline enrollment, especially for rare diseases. This approach promises to deliver more effective, data-driven trials that ultimately benefit patients.

1 of 1

Story summary

Recursion is transforming clinical trials with its innovative AI-powered "ClinTech" strategy, as highlighted by SVP Sid Jain. By embedding AI throughout trial design and execution, the company aims to enhance patient-centric methods and streamline enrollment, especially for rare diseases. This approach promises to deliver more effective, data-driven trials that ultimately benefit patients.